4.8 Article

Direct observation of glucose fingerprint using in vivo Raman spectroscopy

期刊

SCIENCE ADVANCES
卷 6, 期 4, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aay5206

关键词

-

资金

  1. NIH (National Institute of Biomedical Imaging and Bioengineering) [5P41EB15871]
  2. Samsung Advanced Institute of Technology (Suwon, South Korea)
  3. Singapore-MIT Alliance 2 (Cambridge, MA, USA)
  4. BioSym IRG of Singapore-MIT Alliance Research and Technology Center (Cambridge, MA, USA)
  5. Hamamatsu Corporation (Hamamatsu City, Japan)
  6. [U01-NS090438-03]
  7. [R21-NS105070-01]
  8. [R01-HL121386-03]

向作者/读者索取更多资源

Noninvasive blood glucose monitoring has been a long-standing dream in diabetes management. The use of Raman spectroscopy, with its molecular specificity, has been investigated in this regard over the past decade. Previous studies reported on glucose sensing based on indirect evidence such as statistical correlation to the reference glucose concentration. However, these claims fail to demonstrate glucose Raman peaks, which has raised questions regarding the effectiveness of Raman spectroscopy for glucose sensing. Here, we demonstrate the first direct observation of glucose Raman peaks from in vivo skin. The signal intensities varied proportional to the reference glucose concentrations in three live swine glucose clamping experiments. Tracking spectral intensity based on linearity enabled accurate prospective prediction in within-subject and intersubject models. Our direct demonstration of glucose signal may quiet the long debate about whether glucose Raman spectra can be measured in vivo in transcutaneous glucose sensing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据